| __timestamp | BioCryst Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 122000 | 56369000000 |
| Thursday, January 1, 2015 | 1896000 | 62786000000 |
| Friday, January 1, 2016 | 2699000 | 62427000000 |
| Sunday, January 1, 2017 | 1702000 | 62453000000 |
| Monday, January 1, 2018 | 471000 | 65724000000 |
| Tuesday, January 1, 2019 | 4101000 | 70421000000 |
| Wednesday, January 1, 2020 | 1676000 | 80591000000 |
| Friday, January 1, 2021 | 7264000 | 86645000000 |
| Saturday, January 1, 2022 | 6594000 | 100551000000 |
| Sunday, January 1, 2023 | 4661000 | 42907000000 |
| Monday, January 1, 2024 | 115557000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited, a major player from India, has consistently demonstrated robust cost management. From 2014 to 2023, their cost of revenue has shown a steady increase, peaking in 2024 with a 115% rise from 2014. This reflects their strategic expansion and operational efficiency.
Conversely, BioCryst Pharmaceuticals, Inc., a smaller U.S.-based biotech firm, presents a different narrative. Their cost of revenue fluctuated significantly, with a notable spike in 2021, reaching over 7 million, a 58-fold increase from 2014. This volatility highlights the challenges faced by smaller biotech firms in scaling operations.
The data for 2024 is incomplete for BioCryst, indicating potential reporting delays or strategic shifts. These trends underscore the diverse financial landscapes within the pharmaceutical sector, offering insights into strategic cost management.
Cost of Revenue Trends: Merck & Co., Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Trends: Novartis AG vs BioCryst Pharmaceuticals, Inc.
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Trends: Incyte Corporation vs Dr. Reddy's Laboratories Limited
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Pharming Group N.V.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Alkermes plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs HUTCHMED (China) Limited
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Wave Life Sciences Ltd.
Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis